EYEPOINT PHARMACEUTICALS INC. - COMMON STOCK
7.2100
02-5月-25 09:50:28
15 分の遅延
株式
+0.0800
+1.12%
本日の幅
7.0626 - 7.3000
ISIN
N/A
ソース
NASDAQ
-
EyePoint to Report First Quarter 2025 Financial Results on May 7, 2025
30 4 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 4 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
27 3 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17 3 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
05 3 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint Announces Participation at Upcoming Investor Conferences
04 3 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint to Report Fourth Quarter and Full-Year 2024 Financial Results on March 5, 2025
26 2 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint to Present Corporate Update at TD Cowen 45th Annual Health Care Conference
25 2 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
17 2 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
05 2 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint to Present at Guggenheim SMID Cap Biotech Conference
30 1 2025 07:00:00 提供 Nasdaq GlobeNewswire
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16 1 2025 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >